ERYTECH Pharma S.A.
ERYP · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $10 | $49 | $139 | $118 |
| - Cash | $39 | $34 | $44 | $73 |
| + Debt | $14 | $25 | $27 | $14 |
| Enterprise Value | -$16 | $41 | $122 | $59 |
| Revenue | $0 | $0 | $0 | $3 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | -$58 | -$49 |
| % Margin | – | – | – | -1,451.5% |
| EBITDA | -$23 | -$46 | -$67 | $11 |
| % Margin | – | – | – | 332.3% |
| Net Income | -$0 | -$54 | -$73 | -$63 |
| % Margin | – | – | – | -1,862.6% |
| EPS Diluted | -0.007 | -2.27 | -3.99 | -3.49 |
| % Growth | 99.7% | 43.1% | -14.3% | – |
| Operating Cash Flow | -$32 | -$57 | -$52 | -$43 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$20 |
| Free Cash Flow | -$32 | -$57 | -$53 | -$63 |